← Back to Search

Unknown

DS102 2000mg for High Triglycerides (TRIAGE Trial)

Phase 2
Waitlist Available
Research Sponsored by Afimmune
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights

TRIAGE Trial Summary

This trial will compare the effects of a new drug, Epeleuton, to placebo in patients with diabetes and high triglyceride levels. The study will measure how well the drug works and if it is safe.

Eligible Conditions
  • High Triglycerides
  • Type 2 Diabetes

TRIAGE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 26 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HbA1c From Baseline to Week 26
Percent Change in Triglycerides From Baseline to Week 16
Secondary outcome measures
% Change in Triglycerides From Baseline to Weeks 4, 8, 12, 20 and 26
Change in HbA1c From Baseline to Weeks 4, 8, 12, 16 and 20

TRIAGE Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: DS102 4000mgExperimental Treatment1 Intervention
Participants in this group received 2000mg DS102 capsules twice daily.
Group II: DS102 2000mgExperimental Treatment1 Intervention
Participants in this group received 1000mg DS102 capsules twice daily.
Group III: PlaceboPlacebo Group1 Intervention
Participants in this group received placebo capsules twice daily.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DS102
2017
Completed Phase 2
~110

Find a Location

Who is running the clinical trial?

AfimmuneLead Sponsor
4 Previous Clinical Trials
184 Total Patients Enrolled
Markus Weissbach, MDStudy DirectorAfimmune
1 Previous Clinical Trials
219 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes
2020. "Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04365400.
~52 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top